Teva Wins FDA Approval for Schizophrenia Injection Weltruza
Teva Pharmaceutical Industries received U.S. FDA approval for Weltruza, a once-monthly injection for adults with schizophrenia developed in partnership wit
Teva Pharmaceutical Industries received U.S. FDA approval for Weltruza, a once-monthly injection for adults with schizophrenia developed in partnership wit